EMMAC Life Sciences
Vertically integrated European medical cannabis and wellness products.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
* | $286m Valuation: $286m 12.5x EV/Revenue -8.1x EV/EBITDA | Acquisition | |
| Total Funding | 000k | ||
| GBP | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 140 % | 36 % | 40 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | - | (187 %) | (62 %) | (155 %) | (70 %) |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (201 %) | (74 %) | (242 %) | (127 %) |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Notes (0)
More about EMMAC Life Sciences
EditMade with AI
Curaleaf Medical is the scientific arm of Curaleaf International. Our team focuses on advancing our understanding of the potential therapeutic value of cannabis used for medicinal purposes (also known as medical marajuana) and how we can develop products that meet the needs of people all across Europe.
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Investments by EMMAC Life Sciences
Edit
ACQUISITION by EMMAC Life Sciences Jan 2019